Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Addition of GEN-1 to standard NAC shows safety and efficacy in phase I ovarian cancer study

Aug. 2, 2021

Jiangsu Simcere Pharmaceutical R&D discovers MAT2A inhibitors

Aug. 2, 2021

DNA-dependent protein kinase inhibitors discovered at Chengdu Baiyu Pharmaceutical

Aug. 2, 2021

Targeting hypoxia-induced metastatic genes shows therapeutic potential in uveal melanoma

Aug. 2, 2021

HA-121-28 studied in phase II for medullary thyroid carcinoma

July 30, 2021

New SERD discovered by dynamics simulation shows promise for breast cancer therapy

July 30, 2021

Reyoung divulges new autophagy inhibitors

July 30, 2021

New DNA-dependent protein kinase inhibitors identified at Chengdu Baiyu Pharmaceutical

July 30, 2021

Dizal (Jiangsu) Pharmaceutical discovers Bruton tyrosine kinase inhibitors

July 30, 2021

Blueprint Medicines and MD Anderson collaborate on advancing CDK2 inhibitor BLU-222

July 29, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...